Related Experiment Videos
BPL plasma products: new source, enhanced products
1Regional Immunology Department, Birmingham Heartlands Hospital.
Hospital Medicine (London, England : 1998)
|March 4, 2000
Abstract:
Bio Products Laboratory (BPL), the main fractionator of plasma-derived medicines, are undergoing a change from UK plasma to plasma from the USA. BPL aim to maintain continuity of supply and a seamless changeover, despite meticulous cleaning of its production plant and months of auditing by both the organization and regulatory authorities.